Shamim Ruff

SVP, Regulatory Affairs & Qual, Sarepta Therapeutics.

Companies

REATA PHARMACEUTICALS INCBoard member Apr 15, 2021 to Sep 26, 2023¹
Sarepta TherapeuticsSVP, Regulatory Affairs & Qual Sep 30, 2016 to May 24, 2018²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 26, 2023Returned to company 7,359 shares of REATA PHARMACEUTICALS INC³
Jul 28, 2023Sold 8,235 shares at $164.53 of REATA PHARMACEUTICALS INC⁴
Jul 28, 2023Exercised options 319 shares at $92.20 of REATA PHARMACEUTICALS INC⁴
Jul 28, 2023Exercised options 6,666 shares at $92.20 of REATA PHARMACEUTICALS INC⁴
Jul 28, 2023Exercised options 1,250 shares at $92.20 of REATA PHARMACEUTICALS INC⁴
Jun 7, 2023Granted 1,682 shares at $93.61 of REATA PHARMACEUTICALS INC⁵
Jun 7, 2023Granted 454 shares at $93.61 of REATA PHARMACEUTICALS INC⁵
Mar 10, 2023Sold 5,740 shares at $83.73 of REATA PHARMACEUTICALS INC⁶
Mar 10, 2023Exercised options 4,215 shares at $34.76 of REATA PHARMACEUTICALS INC⁶
Mar 10, 2023Exercised options 1,326 shares at $34.76 of REATA PHARMACEUTICALS INC⁶
Mar 10, 2023Exercised options 199 shares at $27.32 of REATA PHARMACEUTICALS INC⁶
Jun 8, 2022Granted 3,883 shares at $34.76 of REATA PHARMACEUTICALS INC⁷
Jun 8, 2022Granted 1,222 shares at $34.76 of REATA PHARMACEUTICALS INC⁷
Jan 3, 2022Granted 118 shares at $27.32 of REATA PHARMACEUTICALS INC⁸

The numbers on this page point here. Each one links to the record it came from.